In a new study, a Yale-led research team uncovers how a very low calorie diet can rapidly reverse type 2 diabetes in animal models. If confirmed in people, the insight provides potential new drug targets for treating this common chronic disease, said the...
The immune system’s response to the Zika virus, rather than the virus itself, may be responsible for nerve-related complications of infection, according to a Yale study. This insight could lead to new ways of treating patients with Zika-related...
Cancer immunotherapy drugs have had notable but limited success because in many cases, tumors develop resistance to treatment. But researchers at Yale and Stanford have identified an experimental antibody that overcomes this problem by targeting a wider...
On Nov. 14 and 15, the National Clinician Scholars Program (NCSP) convened its first national meeting at the Omni Hotel in New Haven.
A successor program to the Robert Wood Johnson Clinical Scholars Program, the NCSP continues its commitment to the...
HIV is more common among individuals in the criminal justice system than among people in the community, but just a fraction of people with HIV in prison or jail receive prompt care after release, say Yale researchers. In a new study published in The...
Hepatitis C infection is a global phenomenon that affects millions worldwide, with an estimated 30,500 new cases in the United States alone each year. Expanding treatment, however, could go a long way toward preventing transmission of the virus among high...